| Year |
Citation |
Score |
| 2009 |
Cangul MZ, Chretien YR, Gutman R, Rubin DB. Testing treatment effects in unconfounded studies under model misspecification: logistic regression, discretization, and their combination. Statistics in Medicine. 28: 2531-51. PMID 19572258 DOI: 10.1002/Sim.3633 |
0.515 |
|
| 2008 |
Gogusev J, Chretien Y, Droz D. Aberrant expression of polycystin-1 in renal cell tumors Macedonian Journal of Medical Sciences. 1: 18-25. DOI: 10.3889/Mjms.1857-5773.2008.0004 |
0.372 |
|
| 2007 |
Loupy A, Anglicheau D, Timsit MO, Thervet E, Mamzer-Bruneel MF, Martinez F, Desgranchamps F, Thiounn N, Kreis H, Legendre C, Chrétien Y, Méjean A. Impact of surgical procedures and complications on outcomes of third and subsequent kidney transplants. Transplantation. 83: 385-91. PMID 17318069 DOI: 10.1097/01.Tp.0000251407.66324.F9 |
0.304 |
|
| 2007 |
Gad S, Lefèvre SH, Khoo SK, Giraud S, Vieillefond A, Vasiliu V, Ferlicot S, Molinié V, Denoux Y, Thiounn N, Chrétien Y, Méjean A, Zerbib M, Benoît G, Hervé JM, et al. Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma. British Journal of Cancer. 96: 336-40. PMID 17133269 DOI: 10.1038/Sj.Bjc.6603492 |
0.334 |
|
| 2007 |
Hupertan V, Rouprêt M, Poisson JF, Chrétien Y, Dufour B, Thiounn N, Méjean A. 550 Low Predictive Accuracy Of Kattan'S Postoperative Nomogram For Renal Cell Carcinoma Recurrence In A Population Of French Patients European Urology Supplements. 6: 160. DOI: 10.1016/S1569-9056(07)60548-X |
0.373 |
|
| 2006 |
Hupertan V, Roupret M, Poisson JF, Chretien Y, Dufour B, Thiounn N, Mejean A. Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients. Cancer. 107: 2604-8. PMID 17075871 DOI: 10.1002/Cncr.22313 |
0.378 |
|
| 2006 |
Timsit MO, Bazin JP, Thiounn N, Fontaine E, Chrétien Y, Dufour B, Méjean A. Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology. 67: 923-6. PMID 16635521 DOI: 10.1016/J.Urology.2005.11.020 |
0.329 |
|
| 2005 |
Lebrun G, Vasiliu V, Bellanné-Chantelot C, Bensman A, Ulinski T, Chrétien Y, Grünfeld JP. Cystic kidney disease, chromophobe renal cell carcinoma and TCF2 (HNF1 beta) mutations. Nature Clinical Practice. Nephrology. 1: 115-9. PMID 16932376 DOI: 10.1038/Ncpneph0054 |
0.35 |
|
| 2005 |
Rebouissou S, Vasiliu V, Thomas C, Bellanné-Chantelot C, Bui H, Chrétien Y, Timsit J, Rosty C, Laurent-Puig P, Chauveau D, Zucman-Rossi J. Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Human Molecular Genetics. 14: 603-14. PMID 15649945 DOI: 10.1093/Hmg/Ddi057 |
0.37 |
|
| 2004 |
Gallou C, Chauveau D, Richard S, Joly D, Giraud S, Olschwang S, Martin N, Saquet C, Chrétien Y, Méjean A, Correas JM, Benoît G, Colombeau P, Grünfeld JP, Junien C, et al. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Human Mutation. 24: 215-24. PMID 15300849 DOI: 10.1002/Humu.20082 |
0.341 |
|
| 2004 |
Rouprêt M, Peraldi MN, Thaunat O, Chrétien Y, Thiounn N, Dufour B, Kreis H, Méjean A. Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking. Transplantation. 77: 146-8. PMID 14724453 DOI: 10.1097/01.Tp.0000097178.78160.F2 |
0.306 |
|
| 2004 |
Mejean A, Corréas M, Bazin P, Balian C, Chrétien Y, Thiounn N, Dufour B, Hélénon O. 286 Symptomatic vascular complications (SVC) after renal tumourectomy: Frequency and treatment European Urology Supplements. 3: 74. DOI: 10.1016/S1569-9056(04)90286-2 |
0.302 |
|
| 2003 |
Roupret M, Hopirtean V, Mejean A, Thiounn N, Dufour B, Chretien Y, Chauveau D, Richard S. Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience. The Journal of Urology. 170: 1752-5. PMID 14532769 DOI: 10.1097/01.Ju.0000092780.85876.De |
0.365 |
|
| 2003 |
Mejean A, Hopirtean V, Bazin JP, Larousserie F, Benoit H, Chrétien Y, Thiounn N, Dufour B. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. The Journal of Urology. 170: 764-7. PMID 12913693 DOI: 10.1097/01.Ju.0000081122.57148.Ec |
0.387 |
|
| 2002 |
Mejean A, Chretien Y, Vogt B, Cazin S, Balian C, Thiounn N, Dufour B. Coloepiploic mobilization during left radical nephrectomy for renal cell carcinoma is indicated to reduce the risk of iatrogenic splenectomy. Urology. 59: 358-61. PMID 11880070 DOI: 10.1016/S0090-4295(01)01549-7 |
0.355 |
|
| 2002 |
Mejean A, Chretien Y, Cazin S, Balian C, Thiounn N, Dufour B. The risk of iatrogenic splenectomy may be reduced by a colo-epiploic mobilisation during left radical nephrectomy for renal cell carcinoma European Urology Supplements. 1: 72. DOI: 10.1016/S1569-9056(02)80275-5 |
0.346 |
|
| 2000 |
Mejean A, Vona G, Nalpas B, Damotte D, Brousse N, Chretien Y, Dufour B, Lacour B, Bréchot C, Paterlini-Bréchot P. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence Journal of Urology. 163: 2022-2029. PMID 10799250 DOI: 10.1016/S0022-5347(05)67621-5 |
0.315 |
|
| 1999 |
Mejean A, Vogt B, Quazza JE, Chretien Y, Dufour B. Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision. European Urology. 36: 298-302. PMID 10473988 DOI: 10.1159/000020008 |
0.342 |
|
| 1999 |
Sabile A, Louha M, Bonte E, Poussin K, Vona G, Mejean A, Chretien Y, Bougas L, Lacour B, Capron F, Roseto A, Bréchot C, Paterlini-Bréchot P. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection American Journal of Clinical Pathology. 112: 171-178. PMID 10439796 DOI: 10.1093/Ajcp/112.2.171 |
0.308 |
|
| 1998 |
Tourani JM, Pfister C, Berdah JF, Benhammouda A, Salze P, Monnier A, Paule B, Guillet P, Chretien Y, Brewer Y, Di Palma M, Untereiner M, Malaurie E, Tadrist Z, Pavlovitch JM, et al. Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: Results of a sequential nonrandomized phase II study Journal of Clinical Oncology. 16: 2505-2513. PMID 9667271 DOI: 10.1200/Jco.1998.16.7.2505 |
0.331 |
|
| 1997 |
Béroud C, Fournet JC, Jeanpierre C, Droz D, Bouvier R, Froger D, Chrétien Y, Maréchal JM, Weissenbach J, Junien C. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes, Chromosomes & Cancer. 17: 215-24. PMID 8946203 DOI: 10.1002/(Sici)1098-2264(199612)17:4<215::Aid-Gcc3>3.0.Co;2-6 |
0.312 |
|
| 1996 |
Cornud F, Belin X, Flam T, Chrétien Y, Deslignieres S, Paraf F, Casanova JM, Thiounn N, Hélénon O, Debré B, Dufour B, Moreau JF. Local staging of prostate cancer by endorectal MRI using fast spin‐echo sequences: prospective correlation with pathological findings after radical prostatectomy Bjui. 77: 843-850. PMID 8705219 DOI: 10.1046/J.1464-410X.1996.01313.X |
0.305 |
|
| 1996 |
Maulard-Durdux C, Dufour B, Hennequin C, Chrétien Y, SDMD, Housset M. Phase II study of the oral cyclophosphamide and oral etoposide combination in hormone-refractory prostate carcinoma patients. Cancer. 77: 1144-1148. PMID 8635136 DOI: 10.1002/(Sici)1097-0142(19960315)77:6<1144::Aid-Cncr21>3.0.Co;2-0 |
0.322 |
|
| 1996 |
Maulard-Durdux C, Dufour B, Hennequin C, Chretien Y, Vignes B, Droz D, Delanian S, Housset M. Postoperative Radiation Therapy in 26 Patients with Invasive Transitional Cell Carcinoma of the Upper Urinary Tract: No Impact on Survival? The Journal of Urology. 155: 115-117. DOI: 10.1016/S0022-5347(01)66563-7 |
0.36 |
|
| 1995 |
Paraf F, Gogusev J, Chretien Y, Droz D. Expression of bcl-2 oncoprotein in renal cell tumours Journal of Pathology. 177: 247-252. PMID 8551386 DOI: 10.1002/Path.1711770306 |
0.349 |
|
| 1994 |
Maulard C, Toubert ME, Chretien Y, Delanian S, Dufour B, Housset M. Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker: A prospective study Cancer. 73: 394-398. PMID 8293406 DOI: 10.1002/1097-0142(19940115)73:2<394::Aid-Cncr2820730226>3.0.Co;2-Y |
0.318 |
|
| 1993 |
Hélénon O, Chrétien Y, Paraf F, Melki P, Denys A, Moreau JF. Renal cell carcinoma containing fat: demonstration with CT. Radiology. 188: 429-430. PMID 8327691 DOI: 10.1148/Radiology.188.2.8327691 |
0.368 |
|
| 1993 |
Housset M, Maulard C, Chretien Y, Dufour B, Delanian S, Huart J, Colardelle F, Brunel P, Baillet F. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study Journal of Clinical Oncology. 11: 2150-2157. PMID 8229129 DOI: 10.1200/Jco.1993.11.11.2150 |
0.325 |
|
| Show low-probability matches. |